Theophylline
Specifications
49746-06-7CAS Number
200-385-7EC Number
1,3-dimethyl-7H-purine-2,6-dioneIUPAC Name
C7H8N4O2Chemical Formula
180.16 g/molMolecular Weight
theophylline; 58-55-9; 1,3-Dimethylxanthine; Elixophyllin; Theophyllin; Theolair; Nuelin; Theophylline anhydrous; Elixophylline; Lanophyllin; Pseudotheophylline; Respbid; Solosin; Theocin; Theo-dur; Liquophylline; Optiphyllin; Parkophyllin; Theofol; Theograd; Acet-theocin; Slo-phyllin; Armophylline; Slo-bid; Doraphyllin; Elixicon; Maphylline; Medaphyllin; Teofyllamin; Theacitin; Theocontin; Theovent; Uniphyllin; Xantivent; Austyn; Elixex; Teolair; Uniphyl; Accurbron; Aerolate III; Bronkodyl; Euphylong; Theophyl-225; Aerolate; Duraphyl; Theobid; Quibron T/SR; 1,3-dimethyl-7H-purine-2,6-dione; Sustaire; Teofilina; Theochron; Asmax; Somophyllin-t; Theal tablets; Theophylline, anhydrous; Bronkodyl SR; Constant-T; Theoclair-SR; Theoclear LA; Quibron-T; Spophyllin retard; Theophyline; Theoclear 80; Theodel; Theostat 80; Theona P; Synophylate-L.A. Cenules; Theo-Dur-Sprinkle; Aquaphyllin; Elixomin; Theolixir; Theophyl; 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione; LaBID; Elixophyllin SR; Theophylline-SR; LASMA; Pro-vent; Somophyllin-CRT; Aerolate SR; Theophyl-SR; Uni-Dur; Theoclear-80; Quibron-T/SR; T-Phyl; Theoclear-200; Theolair-SR; Nuelin SA; Theobid Jr.; Theo-24; Uniphyllin continus; 1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione; Theoclear L.A.-130; Xanthine, 1,3-dimethyl-; NSC 2066; Quibron; Purine-2,6(1H,3H)-dione, 1,3-dimethyl-; 1,3-dimethyl-1H-purine-2,6(3H,7H)-dione; DTXSID5021336; 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-; 0I55128JYK; NSC-2066; Doxophylline metabolite m3; Theophylline [USP]; AEROLATE JR; DTXCID001336; CHEBI:28177; THEOCLEAR-100; NSC2066; Theophylline melting point standard; Constant T; THEOCLEAR L.A.-260; Theobid Duracap; Somophyllin T; Theodur G; Theophylline (USP); NSC-757346; Theo 24; SloPhyllin; SomophyllinT; ConstantT; Slo Phyllin; Theo Dur; Quibron TSR; ct, theo von; von ct, theo; THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER; THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER; Quibron T SR; Theo24; THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER; THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER; THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER; THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER; THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER; THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER; Theophylline (anhydrous); Senophylline; Nuelin sa-250; Theophylline,anhydrous; Anhydrous, Theophylline; RefChem:6299; Theophyllinate, Glycine; Glycinate, Theophylline Sodium; Sodium Glycinate, Theophylline; THEOPHYLLINE ANHYDROUS, CHOLINE; 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrate; 200-385-7; 1,3 Dimethylxanthine; 1,3-Dimethylxanthine Monohydrate; C137DTR5RG; Theolix; Choledyl SA; Theo-11; Tefamin; Unifyl; Euphylline; C7H8N4O2; Bronkotabs; 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione; Theo-Organidin; GS 2591A; X 115; Theal tabl.; MFCD00079619; 1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine; Theodur; CHEMBL190; MLS000069390; 1,3-Dimethylxanthine;Theo-24; 75448-53-2; Aerobin; Diffumal; Teonova; Theopek; Theospan; 1,3-dimethyl-1H-purine-2,6(3H,9H)-dione; Theophylline (1,3-dimethylxanthine); Teofilina [Polish]; NCGC00018117-07; NCGC00018117-17; Mudrane; Pulmidur; SMR000058537; Theokin; Hylate; Bronchodid Duracap; 1,3-dimethyl-1,3,7-trihydropurine-2,6-dione; 49746-06-7; 50857-74-4; 1H-Purine-2,6-dione, 3,9-dihydro-1,3-dimethyl-; Teocen 200; Elixophyllin(e); CAS-58-55-9; Theolair (TN); Elixophyllin (TN); Uniphyl (TN); Quibron-t (TN); Caffeine Impurity 6; Theodur G (TN); CCRIS 4729; HSDB 3399; SR-01000075195; EINECS 200-385-7; Theo-24 (TN); Telbans; Physpa; UNII-0I55128JYK; AI3-50216; Unicontin CR; Theophylline CRS; 4eoh; Aescin-IIA; 58-55-9 (ANHYDROUS); Theophylline form II; theophylline solu-tion; component of Primatene; Xanthine,3-dimethyl-; Opera_ID_76; Spectrum_001038; Theophylline (JP18); 2a3a; Theophylline (Standard); Prestwick0_000820; Prestwick0_000873; Prestwick1_000820; Prestwick1_000873; Prestwick2_000820; Prestwick2_000873; Prestwick3_000820; Prestwick3_000873; Spectrum2_000842; Spectrum3_000672; Spectrum4_000353; Spectrum5_001232; THEOPHYLLINE [MI]; 8-(2-Furyl)theophylline; UPCMLD-DP123; component of Theo-Organidin; EC 200-385-7; SCHEMBL4915; Lopac0_000014; BSPBio_000719; BSPBio_000945; BSPBio_002363; component of Dicurin Procaine; GTPL413; KBioGR_000785; KBioSS_001518; Pentoxifylline EP Impurity F; MLS002152943; MLS002153487; MLS004491910; MLS006011970; BIDD:ER0557; BIDD:GT0151; DivK1c_000203; SPECTRUM1500568; THEOPHYLLINE [USP-RS]; THEOPHYLLINE [WHO-DD]; SPBio_000823; SPBio_002640; SPBio_002866; BPBio1_000791; BPBio1_001041; orb1224582; orb1309828; orb3178736; SCHEMBL2136940; SCHEMBL4435082; SCHEMBL5711097; SCHEMBL8312163; SCHEMBL8595167; component of Tedral (Salt/Mix); UPCMLD-DP123:001; BCBcMAP01_000071; BDBM10847; BDBM82053; component of Quibron (Salt/Mix); HMS500K05; HY-B0809R; KBio1_000203; KBio2_001518; KBio2_004086; KBio2_006654; KBio3_001583; component of Hecadrol (Salt/Mix); NINDS_000203; Theophylline, 1mg/ml in Methanol; HMS1921E03; HMS2089A06; HMS2092M05; HMS2233E16; HMS3259O06; HMS3369N14; Pharmakon1600-01500568; component of Primatene (Salt/Mix); ALBB-036665; component of Bronkotabs (Salt/Mix); HY-B0809; MSK10355; STR01537; Theophylline 1.0 mg/ml in Methanol; Theophylline, >=99.0% (HPLC); Tox21_110827; Tox21_202375; Tox21_300028; CCG-20301; EBC-13437; HB2849; NSC757346; PDSP1_001018; PDSP1_001234; PDSP2_001002; PDSP2_001218; STK397040; THEOPHYLLINE ANHYDROUS [HSDB]; THEOPHYLLINE,ANHYDROUS [VANDF]; AKOS000120961; AKOS005434016; component of Quibron Plus (Salt/Mix); Tox21_110827_1; component of Quibron-T/SR (Salt/Mix); component of Theo-organdin (Salt/Mix); component of Theolair plus (Salt/Mix); CS-4158; DB00277; FT28196; NC00542; Purine-2,3H)-dione, 1,3-dimethyl-; SDCCGMLS-0066620.P001; SDCCGSBI-0050003.P005; TN12345; component of Theo-Organidin (Salt/Mix); IDI1_000203; SMP1_000291; component of Slo-phyllin GG (Salt/Mix); NCGC00018117-01; NCGC00018117-02; NCGC00018117-03; NCGC00018117-04; NCGC00018117-05; NCGC00018117-06; NCGC00018117-08; NCGC00018117-09; NCGC00018117-10; NCGC00018117-11; NCGC00018117-12; NCGC00018117-13; NCGC00018117-14; NCGC00018117-15; NCGC00018117-16; NCGC00018117-18; NCGC00018117-19; NCGC00018117-20; NCGC00018117-23; NCGC00018117-31; NCGC00018117-35; NCGC00018117-37; NCGC00018117-42; NCGC00022112-03; NCGC00022112-04; NCGC00022112-05; NCGC00022112-07; NCGC00022112-08; NCGC00022112-09; NCGC00022112-10; NCGC00022112-11; NCGC00022112-12; NCGC00254040-01; NCGC00259924-01; WLN: T56 BM DN FNVNVJ F1 H1; AC-20328; component of Dicurin Procaine (Salt/Mix); NCI60_001736; SMR003435989; ST024762; SY066799; Theophylline, anhydrous, >=99%, powder; component of Primatene tablets (Salt/Mix); Purine,6(1H,3H)-dione, 1,3-dimethyl-; SBI-0050003.P004; component of Mudrane GG elixir (Salt/Mix); DB-053224; Theophylline 100 microg/mL in Acetonitrile; Theophylline(Discontinued,See C4X-13306); 1H-Purine-2, 3,7-dihydro-1,3-dimethyl-; AB00052106; NS00010258; EN300-21503; C07130; D00371; D85002; DIMENHYDRINATE IMPURITY A [EP IMPURITY]; PENTOXIFYLLINE IMPURITY C [EP IMPURITY]; AB00052106-20; AB00052106-22; AB00052106-23; AB00052106_24; AB00052106_25; AB00052106_26; 1,3-dimethyl-3,9-dihydro-1H-purine-2,6-dione; F095062; L000595; Q407308; 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione #; SR-01000075195-1; SR-01000075195-3; SR-01000075195-5; BRD-K97799481-001-02-0; BRD-K97799481-001-12-9; BRD-K97799481-001-16-0; BRD-K97799481-002-03-6; BRD-K97799481-205-01-9; BRD-K97799481-205-02-7; BRD-K97799481-230-01-7; F2173-0145; Z203045518; A3133D49-AAB6-49A1-B60B-B5198F327D3F; Theophylline, British Pharmacopoeia (BP) Reference Standard; Theophylline, European Pharmacopoeia (EP) Reference Standard; Theophylline melting point standard, United States Pharmacopeia (USP) Reference Standard; Theophylline, Pharmaceutical Secondary Standard; Certified Reference Material; Theophylline;1,3-Dimethylxanthine; 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione; 8061-56-1; Caffeine EP Impurity A; Dimenhydrinate EP Impurity A; Diprophylline EP Impurity B; Pentoxifylline EP Impurity C; InChI=1/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9; Theophylline melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material; Theophylline, certified reference material, United States Pharmacopeia (USP) Reference StandardSynonyms
